Lv7
4210 积分 2021-09-11 加入
Psychological distress and quality of life in Chinese early-stage breast cancer patients throughout chemotherapy
12小时前
已完结
The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors
12小时前
已完结
Current treatment approach and future perspectives in B cell lymphoma
20小时前
已完结
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
3天前
已完结
Application patterns and outcomes of hematopoietic stem cell transplantation in peripheral T-cell lymphoma patients: a multicenter real-world study in China
5天前
已完结
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
5天前
已完结
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
5天前
已完结
Long‐term outcome of peripheral T‐cell lymphomas: Ten‐year follow‐up of the International Prospective T‐cell Project
5天前
已完结
First-line benmelstobart plus anlotinib and chemotherapy in advanced or metastatic/recurrent esophageal squamous cell carcinoma: a multi-center phase 2 study
6天前
已完结
The hallmarks of cancer immune evasion
7天前
已完结
皖公网安备34019202002308
